Publications by authors named "Leng Jinhua"

Endometriosis is a chronic condition with limited therapeutic options. The molecular aberrations promoting ectopic attachment and interactions with the local microenvironment sustaining lesion growth have been unclear, prohibiting development of targeted therapies. Here, we performed single-cell and spatial transcriptomic profiling of ectopic lesions and eutopic endometrium in endometriosis.

View Article and Find Full Text PDF

We talk to Xiaoyue Wang and Jinhua Leng, corresponding authors of "Single-cell and spatial transcriptomic profiling revealed niche interactions sustaining growth of endometriotic lesions" in this issue of Cell Genomics, about their research, the key implications of their study, and their advice for other scientists.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on 45 patients with ovarian endometriosis who experienced recurrent pain after laparoscopic surgery, with a follow-up period averaging over 10 years.
  • Results indicated that a significant number of patients had severe dysmenorrhea pre-surgery, and many had advanced stages of endometriosis and coexisting conditions like adenomyosis.
  • The findings suggest that while cyst recurrence occurred in 24.4% of patients, most reported only pain recurrence, indicating a need for long-term medication to manage symptoms and reduce the risk of recurrence.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the relationship between steroid receptor expression and fibrosis in adenomyosis, focusing on the effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) in alleviating pain.
  • In a cohort of 125 women, those reporting treatment success had higher levels of estrogen and progesterone receptors and less fibrosis compared to those who did not respond, indicating a significant correlation with symptom relief.
  • The findings suggest that lower levels of steroid receptors, particularly estrogen receptor-α in the tumor stroma, may predict treatment failure with LNG-IUS in women suffering from adenomyosis-related dysmenorrhoea.
View Article and Find Full Text PDF

Objective: To investigate the clinical features of bladder endometriosis and factors associated with urinary symptoms, pregnancy outcomes, and long-term effects of symptom relief and recurrence.

Design: A single-center retrospective cohort study.

Setting: A tertiary referral hospital.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate the effectiveness and safety of Sanjie Analgesic Capsule (SAC) in treating pain related to endometriosis in Chinese women, conducted over multiple centers with 323 patients.
  • - Participants were randomized to receive either SAC or a placebo for three menstrual cycles, with pain response measured at 3 and 6 months using a Visual Analogue Scale.
  • - Results showed significant improvements in pain symptoms for the SAC group compared to the placebo, particularly in dysmenorrhea, while the overall safety profile was similar between both groups.
View Article and Find Full Text PDF

Pericytes (PCs) are versatile cells integral to the microcirculation wall, exhibiting specific stem cell traits. They are essential in modulating blood flow, ensuring vascular permeability, maintaining homeostasis, and aiding tissue repair process. Given their involvement in numerous disease-related pathological and physiological processes, the regulation of PCs has emerged as a focal point of research.

View Article and Find Full Text PDF

Purpose: To summarize evidence on levonorgestrel releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis (AM) and to identify potential research gaps.

Methods: Search was conducted in MEDLINE, The Cochrane Library, EMBASE, CBM, CNKI, and Wanfang. We included studies investigating patients with AM treated with LNG-IUS combined with conservative therapy.

View Article and Find Full Text PDF

Objective: This study aimed to explore the distribution of nerve fibers in abdominal wall endometriosis (AWE) and discern their association with pain.

Methods: A retrospective case-control study was conducted. The cases comprised 30 patients diagnosed with AWE, while the control group consisted of 17 patients who had undergone laparotomy without any history of endometriosis.

View Article and Find Full Text PDF

Background: The objective of our study was to investigate the risk factors for a decrease in ovarian reserve in patients with endometriomas after standardized laparoscopic procedures and evaluation to provide corresponding clinical guidance for patients with fertility requirements.

Methods: Anti-Müllerian hormone (AMH) levels and other clinical data from 233 patients with endometriomas and 57 patients with non-endometrioma ovarian cysts admitted to the Peking Union Medical College Hospital between January 2018 and September 2023 were prospectively analysed. The pretreatment AMH levels of the study groups were compared to assess the impact of endometrioma on ovarian reserve, and the decrease in AMH after treatment was analysed to determine potential risk factors contributing to this change.

View Article and Find Full Text PDF

Endometriosis and adenomyosis are two similar gynecological diseases that are characterized by ectopic implantation and the growth of the endometrial tissue. Previous studies have reported that they share a common pathophysiology in some respects, such as a similar cellular composition and resistance to the progestogen of lesions, but their underlying mechanisms remain elusive. Emerging single-cell ribonucleic acid sequencing (scRNA-seq) technologies allow for the dissection of single-cell transcriptome mapping to reveal the etiology of diseases at the level of the individual cell.

View Article and Find Full Text PDF

Background: The aim of the study is to investigate the proportion and clinical features of previous spontaneously ruptured ovarian endometrioma among women who underwent elective surgery for endometrioma.

Methods: This retrospective study was based on a cohort of elective surgeries for endometrioma performed by the same gynecologic team at Peking Union Medical College Hospital from January 2017 to October 2022. Patients diagnosed with previous spontaneously ruptured endometrioma during elective surgery were enrolled in the ruptured group.

View Article and Find Full Text PDF

The purpose of this study was to implore the association among clinical features, long-term fertility outcomes and the anatomical location of adenomyosis identified by ultrasound. We collected data of non-pregnant patients between 20 and 40 years old who had undergone surgical exploration for benign gynecological conditions at our institution between January 2010 and December 2017. A total of 158 women met the inclusion criteria and were allocated into three groups according to the ultrasound-determined adenomyosis anatomical location: anterior (Group A), posterior (Group B), both posterior and anterior (Group C).

View Article and Find Full Text PDF

Objective: To explore potential biomarkers indicating endometriosis (EM).

Materials And Methods: A proteomics method and combined quantitative transcriptomics were adopted to highlight markers in the EM. Venn analysis was used to integrate the ribonucleic acid sequencing (RNA-seq) and protein profiles.

View Article and Find Full Text PDF

Background: When ovarian endometrioma coexist with adenomyosis, the risk of postoperative recurrence increased. How is the effect of levonorgestrel-releasing intrauterine system (LNG-IUS) on symptomatic recurrence for those patients was unknown.

Methods: This study retrospectively analyzed 119 women with coexistent endometrioma and diffuse adenomyosis who received laparoscopic excision of pelvic endometriosis from January 2009 to April 2013.

View Article and Find Full Text PDF

Aim: This systematic review aimed to assess the efficacy and safety of Drospirenone and Ethinylestradiol Tablets (II) in the treatment of dysmenorrhea.

Methods: Electronic databases, namely PubMed, Embase, Cochrane Controlled Register of Trials (CENTRAL), Scopus, Science, CBM, CNKI, Wanfang, and VIP, were searched before September 2022. Randomized controlled trials (RCTs), non-randomized controlled trials, cohort studies, case-control studies, and single-arm studies were included.

View Article and Find Full Text PDF

Background: This retrospective study evaluated the clinical features of perineal endometriosis (PEM) and established a prognostic nomogram for recurrence probability in patients treated with surgical resection.

Methods: This study enrolled 130 PEM patients who had received surgical treatment in Peking Union Medical College Hospital (PUMCH) between January 1992 and September 2020. We collected their clinical features and conducted outpatient or telephone follow-up.

View Article and Find Full Text PDF

Objective: To review the use of oral gonadotropin-releasing hormone (GnRH) antagonists and synthesize their efficacy and safety parameters for the treatment of endometriosis-associated pain.

Design: Systematic review and network meta-analysis.

Setting: Not applicable.

View Article and Find Full Text PDF

Objective: To determine the oncofertility outcomes and prognostic factors in a large series of serous borderline ovarian tumor-micropapillary variant (SBOT-M) with a long-term follow-up.

Methods: Consecutive patients with SBOT-Ms treated from two affiliated hospitals of the Chinese Academy of Medical Sciences were retrospectively reviewed. Prognostic factors on invasive recurrence, disease-free survival (DFS), and overall survival were analyzed, and outcomes of patients treated with conservative and radical surgery were compared.

View Article and Find Full Text PDF

Introduction: There is currently no satisfactory model for predicting malignant transformation of endometriosis. The aim of this study was to construct and evaluate a risk model incorporating noninvasive clinical parameters to predict endometriosis-associated ovarian cancer (EAOC) in patients with endometriosis.

Material And Methods: We enrolled 6809 patients with endometriosis confirmed by pathology, and randomly allocated them to training (n = 4766) and testing cohorts (n = 2043).

View Article and Find Full Text PDF

Introduction: This phase 3, randomized, open-label, active-controlled, multicenter study investigated the efficacy of triptorelin pamoate prolonged-release (PR) 3-month in Chinese patients with endometriosis by demonstrating the noninferiority of the 3-month formulation to the standard of care, triptorelin acetate PR 1-month.

Methods: The trial was conducted in 24 clinical centers in China, and included 300 Chinese women (18-45 years) with endometriosis and regular menstrual cycles who required treatment with a gonadotropin-releasing hormone agonist for 6 months. One group of patients (n = 150) was treated with triptorelin pamoate PR 3-month (15 mg per injection, once every 12 weeks), and the other (n = 150) with triptorelin acetate PR 1-month (3.

View Article and Find Full Text PDF

Background: To examine and compare the differences in clinical characteristics and long-term postoperative outcomes of ovarian endometriomas (OMA) patients with and without dysmenorrhea, including data from at least 8 years of postoperative follow-up examinations.

Methods: Retrospective analysis of 334 OMA patients, including their demographic and clinical data. Long-term follow-up record was also collected.

View Article and Find Full Text PDF